GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Livzon Pharmaceutical Group Inc (SZSE:000513) » Definitions » Price-to-Owner-Earnings

Livzon Pharmaceutical Group (SZSE:000513) Price-to-Owner-Earnings : 30.61 (As of May. 01, 2024)


View and export this data going back to 1993. Start your Free Trial

What is Livzon Pharmaceutical Group Price-to-Owner-Earnings?

As of today (2024-05-01), Livzon Pharmaceutical Group's share price is ¥40.10. Livzon Pharmaceutical Group's Owner Earnings per Share (TTM) ended in Mar. 2024 was ¥1.31. It's Price-to-Owner-Earnings for today is 30.61.


The historical rank and industry rank for Livzon Pharmaceutical Group's Price-to-Owner-Earnings or its related term are showing as below:

SZSE:000513' s Price-to-Owner-Earnings Range Over the Past 10 Years
Min: 5.87   Med: 33.03   Max: 881.32
Current: 30.75

During the past 13 years, the highest Price-to-Owner-Earnings of Livzon Pharmaceutical Group was 881.32. The lowest was 5.87. And the median was 33.03.


SZSE:000513's Price-to-Owner-Earnings is ranked worse than
53.92% of 421 companies
in the Drug Manufacturers industry
Industry Median: 28.39 vs SZSE:000513: 30.75

As of today (2024-05-01), Livzon Pharmaceutical Group's share price is ¥40.10. Livzon Pharmaceutical Group's Earnings per Share (Diluted) for the trailing twelve months (TTM) ended in Mar. 2024 was ¥2.13. Therefore, Livzon Pharmaceutical Group's PE Ratio for today is 18.83.

As of today (2024-05-01), Livzon Pharmaceutical Group's share price is ¥40.10. Livzon Pharmaceutical Group's EPS without NRI for the trailing twelve months (TTM) ended in was ¥2.38. Therefore, Livzon Pharmaceutical Group's PE Ratio without NRI for today is 16.83.

During the past 13 years, Livzon Pharmaceutical Group's highest PE Ratio without NRI was 46.32. The lowest was 5.47. And the median was 22.66.


Livzon Pharmaceutical Group Price-to-Owner-Earnings Historical Data

The historical data trend for Livzon Pharmaceutical Group's Price-to-Owner-Earnings can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Livzon Pharmaceutical Group Price-to-Owner-Earnings Chart

Livzon Pharmaceutical Group Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
Price-to-Owner-Earnings
Get a 7-Day Free Trial Premium Member Only Premium Member Only 33.80 28.91 30.81 24.70 26.64

Livzon Pharmaceutical Group Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
Price-to-Owner-Earnings Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 27.47 26.78 26.42 26.64 27.78

Competitive Comparison of Livzon Pharmaceutical Group's Price-to-Owner-Earnings

For the Drug Manufacturers - Specialty & Generic subindustry, Livzon Pharmaceutical Group's Price-to-Owner-Earnings, along with its competitors' market caps and Price-to-Owner-Earnings data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Livzon Pharmaceutical Group's Price-to-Owner-Earnings Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Livzon Pharmaceutical Group's Price-to-Owner-Earnings distribution charts can be found below:

* The bar in red indicates where Livzon Pharmaceutical Group's Price-to-Owner-Earnings falls into.



Livzon Pharmaceutical Group Price-to-Owner-Earnings Calculation

In 1986 Berkshire Hathaway Shareholder Letter, Warren Buffett defined owner earnings as follows:

"These represent (a) reported earnings plus (b) depreciation, depletion, amortization, and certain other non-cash charges...less (c) the average annual amount of capitalized expenditures for plant and equipment, etc. that the business requires to fully maintain its long-term competitive position and its unit volume. (If the business requires additional working capital to maintain its competitive position and unit volume, the increment also should be included in (c))...Our owner-earnings equation does not yield the deceptively precise figures provided by GAAP, since (c) must be a guess - and one sometimes very difficult to make. Despite this problem, we consider the owner earnings figure, not the GAAP figure, to be the relevant item for valuation purposes - both for investors in buying stocks and for managers in buying entire businesses...All of this points up the absurdity of the 'cash flow' numbers that are often set forth in Wall Street reports. These numbers routinely include (a) plus (b) - but do not subtract (c)."

Livzon Pharmaceutical Group's Price-to-Owner-Earnings for today is calculated as

Price-to-Owner-Earnings=Share Price/Owner Earnings per Share (TTM)
=40.10/1.31
=30.61

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Livzon Pharmaceutical Group  (SZSE:000513) Price-to-Owner-Earnings Explanation

For how to get Owner Earnings per Share (TTM), please click.


Livzon Pharmaceutical Group Price-to-Owner-Earnings Related Terms

Thank you for viewing the detailed overview of Livzon Pharmaceutical Group's Price-to-Owner-Earnings provided by GuruFocus.com. Please click on the following links to see related term pages.


Livzon Pharmaceutical Group (SZSE:000513) Business Description

Traded in Other Exchanges
Address
38 Chuangye North Road, Headquarters Building, Jinwan District, Guangdong Province, Zhuhai, CHN, 519090
Livzon Pharmaceutical Group Inc is engaged in China's healthcare sector. As a pharmaceutical manufacturer, the company's portfolio comprises Western pharmaceutical preparations, bulk drugs, traditional Chinese medicines, as well as diagnostic reagents and equipment. Its drug address serious conditions such as gastrointestinal, cardiovascular, anti-infectious, antimicrobial, antineoplastic, hemopoietic system, and other conditions. It distributes its products within domestic markets and to overseas markets. It operates in a single reportable segment which is pharmaceutical manufacturing.

Livzon Pharmaceutical Group (SZSE:000513) Headlines

No Headlines